SURG vs IRIX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 04, 2026

SURG

40.3
AI Score
VS
IRIX Wins

IRIX

42.4
AI Score

Investment Advisor Scores

SURG

40score
Recommendation
HOLD

IRIX

42score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric SURG IRIX Winner
Revenue 15.98M 11.80M SURG
Net Income -12.05M -524,000 IRIX
Net Margin -75.4% -4.4% IRIX
Operating Income -11.20M -324,000 IRIX
ROE 50.6% -11.1% SURG
ROA -126.8% -1.9% IRIX
Total Assets 9.50M 28.27M IRIX
Cash 1.99M 4.59M IRIX
Current Ratio 0.27 1.92 IRIX

Relative Price Performance (Last 90 Days)

SURG 1M: -19.6% · 3M: -40.7% IRIX 1M: -25.0% · 3M: -19.2%

Current Technical Phase

SURG

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 53

RSI (14): 53.4 · Price: $0.32

IRIX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.2%), weak momentum, RSI 25

RSI (14): 25.3 · Price: $0.84

Fundamentals Snapshot

Metric SURG IRIX
Market Cap
Forward P/E 4.5 41.0
Trailing P/E
Revenue (TTM)
Revenue Growth 0.5% 0.0%
Gross Margin -0.2% 0.4%
Operating Margin -0.7% 0.0%
EPS -1.93 -0.19
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, IRIX is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.